While the uptick in the percentage of U.S. children diagnosed with attention-deficit/hperactivity di...

The Food and Drug Administration (FDA) last week approved Vraylar (cariprazine), a dopamine D2/D3 re...

There does not appear to be any significant association between a history of childhood adversity and...

A reanalysis of data from a 2001 study that concluded paroxetine to be generally well tolerated and ...

Yesterday, the Food and Drug Administration announced that it is making changes to the requirements ...

After serving 13 years as director of the National Institute of Mental Health (NIMH), Thomas Insel, ...

Older adults with vitamin D deficiencies showed more rapid cognitive decline than those with adequat...

Twenty-one medical and advocacy organizations have joined in APA’s campaign urging fashion designer ...

Although it is well established that patients with schizophrenia have deficits in cortical gray matt...